Chinese PE Firm Shiyu Capital Leads Over $14M Series Pre-A Round In Biotech Start-Up

Login to View

Biotheus, a Chinese start-up that specializes in the discovery and development of therapeutic biologics in the oncology disease space, announced on Wednesday that it has raised over RMB100 million (US$14.51 million) in a series pre-A round of financing led by Chinese healthcare-focused private equity firm Shiyu Capital.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS